Cardio, as a prescriber , what’s your opinion on AMRN ‘ marketing efforts to date ?
Do U think most Cardiologists learn about Vascepa from a sales rep , medical journal or professional online services like UpToDate or PracticeUpdate etc
I know marketing efforts will ramp up following label expansion ... but what’s your opinion on AMRN ‘ efforts to date .
Some here feel AMRN can’t effectively market Vascepa themselves in the US .
Market Data 
Markets 
AI
